BIO Fe-antibiotic Hydrogels as a Novel Antibiotic Treatment against Gram-Negative Bacteria
BIO Fe-antibiotic Hydrogels as a Novel Antibiotic Treatment against Gram-Negative Bacteria
批准号:
2587292
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --
中文摘要
根据我从学位和额外工作中获得的知识,我希望对具有纳米抗生素潜力的物质的产生和应用进行研究。纳米材料,如银(Ag),由于其抗菌性能,已被用于伤口敷料和可重复使用的购物袋衬里,而纳米材料一般被认为使用不同的机制,以造成细菌死亡。银只是已知具有这些特性的纳米材料之一,尽管其他材料,如铜,氧化锌,钛和二氧化硅,也被认为具有这种可开发的特征。也有人认为,与其他也被认为是未来抗菌替代品的新疗法相比,纳米材料可能具有与其使用相关的较低毒性水平。考虑到这一点,纳米材料的临床使用可能比其他可能具有更严重脱靶毒性的物质更有利。纳米材料所具有的抗菌特性使其成为临床(和潜在环境)使用抗生素的有吸引力的替代品。我的目的是比较标准抗生素的抗菌活性和趋势,纳米材料(以前描述为抗菌)和与铁(Fe)结合的纳米材料。铁是细菌致病所必需的微量营养素,也是细菌繁殖后代所必需的。通过将每种纳米材料与Fe结合,有可能增加纳米材料向细菌的递送,同时可能增强抗菌效果。该项目的概念集中在使用纳米材料-Fe缀合物来靶向目前被认为对人类最有问题的细菌;那些具有几种已知抗生素耐药性的细菌。对于最终用于临床的新型疗法,重要的是要了解哪些物质可能对人体系统产生的影响。该项目旨在通过将哺乳动物细胞纳入实验来考虑这一点。为了深入了解与毒性相关的潜在副作用,提供有关其未来临床使用的有意义的结论(与生理相关的结论),这一点至关重要。此外,通过使用细胞系,如Caco-2细胞,这将减少研究中对动物的需求,这可能是浪费和不道德的,此外不需要内政部批准,这将需要使用动物和原代细胞实验。(停止细菌生长所需的物质的最低浓度),这可以给出每种治疗条件(抗生素、单独的纳米材料或纳米材料-Fe缀合)的功效的指示。如果纳米材料能够发挥其抗菌特性,则与抗生素相比,预期具有已知抗性的细菌在用纳米材料和纳米材料-Fe缀合物处理时将具有较低的MIC。同时,纳米材料-Fe缀合可有助于将纳米材料递送至细菌,因为这些生物体具有几种机制,有助于Fe从细菌的外部环境中吸收和移动,穿过细胞被膜,并进入细胞的内部区域,周质。
英文摘要
From the knowledge I have gained from my degree and additional work, I hope to conduct research into the generation and application of substances with the potential to act as nanoantibiotics. Nanomaterials, such as silver (Ag), have already been used in wound dressings and as linings in reusable shopping bags due to their antimicrobial properties, whilst nanomaterials in general are thought to use different mechanisms in order to inflict bacterial death. Ag is just one nanomaterial which is known to have these characteristics, although others, such as copper, zinc oxide, titanium and silica, are also considered to share this exploitable feature. It has also been suggested that nanomaterials may have lower toxicity levels associated with their use, in comparison to other novel therapies also considered to be future antibacterial alternatives. In considering this, nanomaterials' clinical usage could be more favourable than other substances which could have more severe off- target toxicities.The antibacterial properties possessed by nanomaterials make them an attractive alternative to the clinical (and potentially environmental) use of antibiotics. My intention is to compare the antibacterial activity and tendencies of standard antibiotics to nanomaterials (those previously described as being antibacterial) and nanomaterials conjugated with iron (Fe). Fe is an essential micronutrient which bacteria require to be pathogenic (that being disease-causing) and in order to make more bacterial progeny. By conjugating each nanomaterial with Fe there is the potential to increase nanomaterial delivery to bacteria alongside possible enhanced antibacterial effect. The concept of this project focusses on using the nanomaterial-Fe conjugations to target bacteria currently considered the most problematic to humans; those with several known antibiotic resistances.For a novel therapy to eventually be used clinically, it is important to understand the effects which substances might have on the human system. This project aims to take this into account, by incorporating mammalian cells into experiments. This is crucial to involve in order to gain insight into potential side effects associated with toxicity, providing meaningful conclusions, those which are relevant physiologically, to be made concerning their future clinical use. Moreover, by using a cell line, such as Caco-2 cells, this will reduce the requirement for animals in research which can be wasteful and unethical in addition to not requiring Home Office approval which would be required for use of animals and also experimentation on primary cells.By investigating the minimum inhibitory concentration (MIC) (the lowest concentration of a substance required to stop bacterial growth), this can give an indication of the efficacy of each treatment condition (antibiotic, nanomaterial alone or nanomaterial-Fe conjugation). It would be expected that bacteria with known resistances would have a lower MIC when treated with nanomaterial and nanomaterial-Fe conjugation, in comparison to antibiotic if the nanomaterials are able to exert their antibacterial properties. Whilst, nanomaterial-Fe conjugation may aide the delivery of nanomaterial to bacteria, as these organisms have several mechanisms aiding the uptake and movement of Fe from the bacterium's external environment, across the cell envelope, and into the internal region of the cell, the periplasm.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
去铁胺修饰Fe3+-鞣花酸纳米酶敷料靶向杀灭MRSA促进糖尿病伤口愈合机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢颖
-
依托单位:
基于lip@Cu-Cy&Fe₃O₄磁纳米机器人的介入-光动力/铜死亡协同治疗肝癌新策略研究
-
批准号:2026JJ50325
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈翔宇
-
依托单位:
Fe3O4改性海绵填料强化生物过滤去除废气中苯系物的性能及机制
-
批准号:2026JJ60205
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邬鑫
-
依托单位:
3D打印Fe/Mn双组分多层孔道电极电化学靶向回收浮选复合废水中Sb(V)的机理研究
-
批准号:2026JJ50213
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:侯保林
-
依托单位:
E3泛素连接酶HERC2介导NCOA4-FTH-Fe轴调控神经元铁自噬在机械性脊髓损伤中的作用及机制研究
-
批准号:2026JJ81936
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘富兵
-
依托单位:
基于双位点调控的Fe3O4诱发类芬顿反应降解制药废水中抗生素的性能及机理研究
-
批准号:JCZRQNB202600832
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于Fe 催化调控碳结构构筑高性能 Si/C 锂离子电池负极材料及机制研究
-
批准号:ZCLMS26B0101
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:田青华
-
依托单位:
元素微量掺杂诱发Fe基合金大磁致伸缩效应的研究
-
批准号:2026JJ80313
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周超
-
依托单位:
锌通过调节 SoxR 中[2Fe-2S]簇稳态调控肠杆菌科 SoxS-SOD 轴参与氧化应激机制及抗菌应用研究
-
批准号:ZCLZ26C0101
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭国强
-
依托单位:
基于分子模型精准解析Fe-N-C催化剂氧还原位点动态演化与稳定性机制
-
批准号:2026JJ60344
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵匡民
-
依托单位: